Earnings

Which Market Offer More Value? – Sanofi American Depositary Shar (SNY), Coca-Cola European Partners plc (CCE)

The shares of Sanofi American Depositary Shar have decreased by more than -2.51% this year alone. The shares recently went down by -1.34% or -$0.57 and now trades at $41.92. The shares of Coca-Cola European Partners plc (NYSE:CCE), has jumped by 6.98% year to date as of 08/09/2018. The shares currently trade at $42.63 and have been able to report a change of 5.99% over the past one week.

The stock of Sanofi American Depositary Shar and Coca-Cola European Partners plc were two of the most active stocks on Thursday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Next 5Y EPS Growth: 6.80% versus 11.06%

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that SNY will grow it’s earning at a 6.80% annual rate in the next 5 years. This is in contrast to CCE which will have a positive growth at a 11.06% annual rate. This means that the higher growth rate of CCE implies a greater potential for capital appreciation over the years.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. The ROI of SNY is 5.50% while that of CCE is 8.90%. These figures suggest that CCE ventures generate a higher ROI than that of SNY.

Cash Flow



The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, SNY’s free cash flow per share is a positive 0.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for SNY is 1.20 and that of CCE is 1.00. This implies that it is easier for SNY to cover its immediate obligations over the next 12 months than CCE. The debt ratio of SNY is 0.51 compared to 0.87 for CCE. CCE can be able to settle its long-term debts and thus is a lower financial risk than SNY.

Valuation

SNY currently trades at a forward P/E of 11.82, a P/B of 1.61, and a P/S of 2.64 while CCE trades at a forward P/E of 14.67, a P/B of 2.63, and a P/S of 1.62. This means that looking at the earnings, book values and sales basis, SNY is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions




The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of SNY is currently at a -8.87% to its one-year price target of 46.00. Looking at its rival pricing, CCE is at a 13.44% relative to its price target of 37.58.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), SNY is given a 2.20 while 2.50 placed for CCE. This means that analysts are more bullish on the outlook for CCE stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for SNY is 1.98 while that of CCE is just 1.27. This means that analysts are more bullish on the forecast for CCE stock.

Conclusion

The stock of Sanofi American Depositary Shar defeats that of Coca-Cola European Partners plc when the two are compared, with SNY taking 6 out of the total factors that were been considered. SNY happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, SNY is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for SNY is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

Which Market Offer More Value? – Cesca Thera... The shares of Cesca Therapeutics Inc. have decreased by more than -85.35% this year alone. The shares recently went up by 17.17% or $0.06 and now trad...
Which of 2 stocks would appeal to long-term invest... The shares of Chubb Limited have decreased by more than -9.77% this year alone. The shares recently went down by -1.24% or -$1.66 and now trades at $1...
Which Market Offer More Value? – Host Hotels... The shares of Host Hotels & Resorts, Inc. have increased by more than 4.23% this year alone. The shares recently went down by -0.58% or -$0.12 an...
Comparing Valuation And Performance: Barnes &... The shares of Barnes & Noble, Inc. have decreased by more than -15.67% this year alone. The shares recently went up by 0.89% or $0.05 and now tra...
Taking Tally Of Microchip Technology Incorporated ... The shares of Microchip Technology Incorporated have decreased by more than -0.43% this year alone. The shares recently went down by -0.98% or -$0.87 ...